What does APOTHEEK MONNENS do?

APOTHEEK MONNENS is a pharmacy in Maaseik. Private Limited, started on 27 June 1988, 1 establishment.

What is the address of APOTHEEK MONNENS?

The registered office of APOTHEEK MONNENS is located at Voorshoventerweg 6 box A, 3680 Maaseik.

Is APOTHEEK MONNENS still active?

Yes. According to the CBE (30 October 2026) APOTHEEK MONNENS is active, legal situation “Normale toestand”, started on 27 June 1988.

Is APOTHEEK MONNENS registered on Peppol?

Yes, APOTHEEK MONNENS is registered on the Peppol network with ID 0208:0434654525.

What is the enterprise number of APOTHEEK MONNENS?

The enterprise number of APOTHEEK MONNENS is BE0434654525.

When was APOTHEEK MONNENS founded?

APOTHEEK MONNENS was founded on 27 June 1988.

Who are the directors of APOTHEEK MONNENS?

According to the 2025 annual accounts, the directors of APOTHEEK MONNENS are: Bremonde BV, Olloma BV.

Is APOTHEEK MONNENS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 June 1988; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did APOTHEEK MONNENS make in 2025?

APOTHEEK MONNENS posted a profit after taxes of € 368,328 in financial year 2025.

What is the revenue of APOTHEEK MONNENS?

As a small company, APOTHEEK MONNENS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 642,175.

How much does an employee at APOTHEEK MONNENS earn?

The average wage cost per full-time employee at APOTHEEK MONNENS was € 40,500 in 2025: staff costs of € 141,663 for 3.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK MONNENS have?

According to the 2025 annual accounts, APOTHEEK MONNENS has 3.5 full-time equivalents (FTE).

APOTHEEK MONNENS (Private Limited) - Maaseik

Dossier APOTHEEK MONNENS, printed on 30 October 2026 from databakkes.be/en/0434654525/apotheek-monnens. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 44 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

APOTHEEK MONNENS from Maaseik, company number BE0434654525, closed financial year 2025 with a result of € 368,328 after tax. For that financial year APOTHEEK MONNENS recorded a gross margin of € 642,175 and equity of € 884,264. Compared with financial year 2024, the result moved from € 246,718 to € 368,328. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.

What it is worth Growing

€ 884,264

▲ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 368,328

▲ 49% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 172,938

▲ 29% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 335,000 paid out

91 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

3.5

▲ 0.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 141,663

▲ 41% vs 2024

€ 40,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 6,065

▼ 30% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 9 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 285,518

▼ 9% vs 2024

€ 30,301 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.

Owed to suppliers

€ 147,656

▲ 2% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 26,745

▼ 10% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 549,393 Gross margin 2022: € 549,393 First fiscal year in the series	€ 488,775 Gross margin 2023: € 488,775 ▼ 11% vs 2022 (€ 549,393) Unfavourable step	€ 461,776 Gross margin 2024: € 461,776 ▼ 6% vs 2023 (€ 488,775) Unfavourable step	€ 642,175 Gross margin 2025: € 642,175 ▲ 39% vs 2024 (€ 461,776) Favourable step	▲ 39%
Profit after taxes	€ 414,168 Profit after taxes 2022: € 414,168 First fiscal year in the series	€ 346,238 Profit after taxes 2023: € 346,238 ▼ 16% vs 2022 (€ 414,168) Unfavourable step	€ 246,718 Profit after taxes 2024: € 246,718 ▼ 29% vs 2023 (€ 346,238) Unfavourable step	€ 368,328 Profit after taxes 2025: € 368,328 ▲ 49% vs 2024 (€ 246,718) Favourable step	▲ 49%
Equity	€ 775,980 Equity 2022: € 775,980 First fiscal year in the series	€ 799,218 Equity 2023: € 799,218 ▲ 3% vs 2022 (€ 775,980) Favourable step	€ 850,936 Equity 2024: € 850,936 ▲ 6% vs 2023 (€ 799,218) Favourable step	€ 884,264 Equity 2025: € 884,264 ▲ 4% vs 2024 (€ 850,936) Favourable step	▲ 4%
Total debts	€ 871,972 Total debts 2022: € 871,972 First fiscal year in the series	€ 1,099,632 Total debts 2023: € 1,099,632 ▲ 26% vs 2022 (€ 871,972) Unfavourable step	€ 1,504,864 Total debts 2024: € 1,504,864 ▲ 37% vs 2023 (€ 1,099,632) Unfavourable step	€ 1,522,300 Total debts 2025: € 1,522,300 ▲ 1% vs 2024 (€ 1,504,864) Unfavourable step	▲ 1%
Cash	€ 352,921 Cash 2022: € 352,921 First fiscal year in the series	€ 224,995 Cash 2023: € 224,995 ▼ 36% vs 2022 (€ 352,921) Unfavourable step	€ 134,147 Cash 2024: € 134,147 ▼ 40% vs 2023 (€ 224,995) Unfavourable step	€ 172,938 Cash 2025: € 172,938 ▲ 29% vs 2024 (€ 134,147) Favourable step	▲ 29%
Land & buildings	€ 233,149 Land & buildings 2022: € 233,149 First fiscal year in the series	€ 241,613 Land & buildings 2023: € 241,613 ▲ 4% vs 2022 (€ 233,149) Unchanged	€ 1,205,759 Land & buildings 2024: € 1,205,759 ▲ € 964,146 vs 2023 (€ 241,613) Unchanged	€ 1,154,063 Land & buildings 2025: € 1,154,063 ▼ 4% vs 2024 (€ 1,205,759) Unchanged	▼ 4%
Retained profit	€ 739,783 Retained profit 2022: € 739,783 First fiscal year in the series	€ 763,021 Retained profit 2023: € 763,021 ▲ 3% vs 2022 (€ 739,783) Favourable step	€ 814,738 Retained profit 2024: € 814,738 ▲ 7% vs 2023 (€ 763,021) Favourable step	€ 848,066 Retained profit 2025: € 848,066 ▲ 4% vs 2024 (€ 814,738) Favourable step	▲ 4%
Dividend	€ 348,000 Dividend 2022: € 348,000 First fiscal year in the series	€ 323,000 Dividend 2023: € 323,000 ▼ 7% vs 2022 (€ 348,000) Unchanged	€ 195,000 Dividend 2024: € 195,000 ▼ 40% vs 2023 (€ 323,000) Unchanged	€ 335,000 Dividend 2025: € 335,000 ▲ 72% vs 2024 (€ 195,000) Unchanged	▲ 72%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 314,798 Bank debt 2024: € 314,798 Unchanged (€ 0) Unfavourable step	€ 285,518 Bank debt 2025: € 285,518 ▼ 9% vs 2024 (€ 314,798) Favourable step	▼ 9%
Balance sheet total	€ 1,647,952 Balance sheet total 2022: € 1,647,952 First fiscal year in the series	€ 1,898,849 Balance sheet total 2023: € 1,898,849 ▲ 15% vs 2022 (€ 1,647,952) Unchanged	€ 2,355,800 Balance sheet total 2024: € 2,355,800 ▲ 24% vs 2023 (€ 1,898,849) Unchanged	€ 2,406,564 Balance sheet total 2025: € 2,406,564 ▲ 2% vs 2024 (€ 2,355,800) Unchanged	▲ 2%
Employees (FTE)	2.9 Employees (FTE) 2022: 2.9 First fiscal year in the series	2.9 Employees (FTE) 2023: 2.9 Unchanged (2.9) Unchanged	2.9 Employees (FTE) 2024: 2.9 Unchanged (2.9) Unchanged	3.5 Employees (FTE) 2025: 3.5 ▲ 0.6 vs 2024 (2.9) Unchanged	▲ 0.6

Key figures of APOTHEEK MONNENS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK MONNENS?

What happened at APOTHEEK MONNENS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 30, 2026 New annual accounts for financial year 2025: profit of € 368,328 (▲ 49% vs 2024). filed late Source: NBB ↗
Sep 5, 1988 New establishment in Maaseik. KBO
Jun 27, 1988 Start of the company according to the CBE. KBO

In short

From € 414,168 profit in 2022 to € 368,328 profit in 2025.

Paid € 70,447 in corporate taxes since 2022.

Best year ever: 2022, with € 414,168 profit.

On average € 183,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Bremonde BV Olloma BV

APOTHEEK MONNENS

Behind APOTHEEK MONNENS are Bremonde BV and Olloma BV.

Directors

According to the 2025 annual accounts

Bremonde BV

Director · represented by Monnens Ruth

Olloma BV

Director · represented by Monnens Bert

Establishments

Establishment units

Physical locations of this company

Registered office

Voorshoventerweg 6 box A

3680 Maaseik

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0434.654.525

VAT number

BE 0434.654.525

Registered office

Voorshoventerweg 6 bus A, 3680 Maaseik

Names & denominations

APOTHEEK MONNENS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

27 June 1988

Peppol

Active · Active since 26 Jun 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK MONNENS

Warning lights

Financials

What happened to APOTHEEK MONNENS?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions